325 related articles for article (PubMed ID: 20504889)
1. Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion.
Apodaca-Cruz A; Villarreal-Garza C; Torres-Avila B; Torres J; Meneses A; Flores-Estrada D; Lara-Medina F; Arrieta O
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):154-61. PubMed ID: 20504889
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of symptomatic pericardial effusion in patients with solid malignancies.
Gross JL; Younes RN; Deheinzelin D; Diniz AL; Silva RA; Haddad FJ
Ann Surg Oncol; 2006 Dec; 13(12):1732-8. PubMed ID: 17028771
[TBL] [Abstract][Full Text] [Related]
3. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion.
Swanson N; Mirza I; Wijesinghe N; Devlin G
Catheter Cardiovasc Interv; 2008 Mar; 71(4):504-7. PubMed ID: 18307242
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion.
Gornik HL; Gerhard-Herman M; Beckman JA
J Clin Oncol; 2005 Aug; 23(22):5211-6. PubMed ID: 16051963
[TBL] [Abstract][Full Text] [Related]
5. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
Dequanter D; Lothaire P; Berghmans T; Sculier JP
Ann Surg Oncol; 2008 Nov; 15(11):3268-71. PubMed ID: 18648881
[TBL] [Abstract][Full Text] [Related]
6. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management.
Ashikhmina EA; Schaff HV; Sinak LJ; Li Z; Dearani JA; Suri RM; Park SJ; Orszulak TA; Sundt TM
Ann Thorac Surg; 2010 Jan; 89(1):112-8. PubMed ID: 20103217
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.
Tsang TS; Seward JB; Barnes ME; Bailey KR; Sinak LJ; Urban LH; Hayes SN
Mayo Clin Proc; 2000 Mar; 75(3):248-53. PubMed ID: 10725950
[TBL] [Abstract][Full Text] [Related]
8. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions.
Girardi LN; Ginsberg RJ; Burt ME
Ann Thorac Surg; 1997 Nov; 64(5):1422-7; discussion 1427-8. PubMed ID: 9386714
[TBL] [Abstract][Full Text] [Related]
9. Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability.
Wagner PL; McAleer E; Stillwell E; Bott M; Rusch VW; Schaffer W; Huang J
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):34-8. PubMed ID: 21092993
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of idiopathic chronic pericardial effusion.
Sagristà-Sauleda J; Angel J; Permanyer-Miralda G; Soler-Soler J
N Engl J Med; 1999 Dec; 341(27):2054-9. PubMed ID: 10615077
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of pericardial effusion in patients with neoplastic disease.
Maisch B; Ristic A; Pankuweit S
Prog Cardiovasc Dis; 2010; 53(2):157-63. PubMed ID: 20728703
[TBL] [Abstract][Full Text] [Related]
12. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of surgical subxiphoid pericardial drainage and percutaneous pericardial drainage in pericardial effusions associated with cardiac tamponade.
Petcu CP; Droc I
Chirurgia (Bucur); 2013; 108(2):226-33. PubMed ID: 23618573
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.
El Haddad D; Iliescu C; Yusuf SW; William WN; Khair TH; Song J; Mouhayar EN
J Am Coll Cardiol; 2015 Sep; 66(10):1119-28. PubMed ID: 26337990
[TBL] [Abstract][Full Text] [Related]
15. Balloon pericardiotomy for malignant effusion: first at bat or on-deck hitter?
Goldstein JA
Catheter Cardiovasc Interv; 2008 Mar; 71(4):508-9. PubMed ID: 18307229
[No Abstract] [Full Text] [Related]
16. [Women and pericardial neoplastic manifestations of the heart and pericardium].
Kisselbach C; Ristic AD; Pankuweit S; Karatolius K; Maisch B
Herz; 2005 Aug; 30(5):409-15; quiz 429-30. PubMed ID: 16132244
[TBL] [Abstract][Full Text] [Related]
17. Triage and management of pericardial effusion.
Imazio M; Mayosi BM; Brucato A; Markel G; Trinchero R; Spodick DH; Adler Y
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):928-35. PubMed ID: 20814314
[TBL] [Abstract][Full Text] [Related]
18. eComment: Pericardial sclerosis with cisplatin following pericardiocentesis. A simple and effective technique for the management of refractory malignant pericardial effusions.
Barbetakis N; Asteriou C; Lafaras C; Bischiniotis T
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):161. PubMed ID: 20628020
[No Abstract] [Full Text] [Related]
19. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996).
Dunning D; Monnet E; Orton EC; Salman MD
J Am Vet Med Assoc; 1998 Apr; 212(8):1276-80. PubMed ID: 9569169
[TBL] [Abstract][Full Text] [Related]
20. VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study.
Neragi-Miandoab S; Linden PA; Ducko CT; Bueno R; Richards WG; Sugarbaker DJ; Jaklitsch MT
Int J Surg; 2008 Apr; 6(2):110-4. PubMed ID: 18329349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]